188 related articles for article (PubMed ID: 33655683)
1. A case report of tigecycline induced acute pancreatitis in a renal transplant patient and review of the literature: Should we avoid tigecycline in patients on calcineurin inhibitors?
Yazirli B; Kara E; Inkaya AC; Maden S; Ozberk U; Yildirim T; Parlak E; Uzun O; Yilmaz SR; Arici M
Transpl Infect Dis; 2021 Aug; 23(4):e13593. PubMed ID: 33655683
[TBL] [Abstract][Full Text] [Related]
2. Tigecycline-induced acute pancreatitis in a renal transplant patient: a case report and literature review.
Lin J; Wang R; Chen J
BMC Infect Dis; 2018 May; 18(1):201. PubMed ID: 29720098
[TBL] [Abstract][Full Text] [Related]
3. Acute pancreatitis associated with everolimus after kidney transplantation: a case report.
Fontana F; Cappelli G
BMC Nephrol; 2016 Oct; 17(1):163. PubMed ID: 27793122
[TBL] [Abstract][Full Text] [Related]
4. Acute pancreatitis caused by tigecycline: A case report and literature review.
Wang PF; Zou H; Zhu JH; Shi FE
Medicine (Baltimore); 2021 Dec; 100(51):e28245. PubMed ID: 34941095
[TBL] [Abstract][Full Text] [Related]
5. Preserving renal function in liver transplant recipients with rabbit anti-thymocyte globulin and delayed initiation of calcineurin inhibitors.
Bajjoka I; Hsaiky L; Brown K; Abouljoud M
Liver Transpl; 2008 Jan; 14(1):66-72. PubMed ID: 18161842
[TBL] [Abstract][Full Text] [Related]
6. Tigecycline-induced acute pancreatitis: case report and literature review.
Hung WY; Kogelman L; Volpe G; Iafrati M; Davidson L
Int J Antimicrob Agents; 2009 Nov; 34(5):486-9. PubMed ID: 19540093
[TBL] [Abstract][Full Text] [Related]
7. Tigecycline-induced acute pancreatitis: about two cases and review of the literature.
Marot JC; Jonckheere S; Munyentwali H; Belkhir L; Vandercam B; Yombi JC
Acta Clin Belg; 2012; 67(3):229-32. PubMed ID: 22897076
[TBL] [Abstract][Full Text] [Related]
8. A calcineurin inhibitor-sparing regimen with sirolimus, mycophenolate mofetil, and anti-CD25 mAb provides effective immunosuppression in kidney transplant recipients with delayed or impaired graft function.
Chang GJ; Mahanty HD; Vincenti F; Freise CE; Roberts JP; Ascher NL; Stock PG; Hirose R
Clin Transplant; 2000 Dec; 14(6):550-4. PubMed ID: 11127307
[TBL] [Abstract][Full Text] [Related]
9. Basiliximab: a review of its use as induction therapy in renal transplantation.
Chapman TM; Keating GM
Drugs; 2003; 63(24):2803-35. PubMed ID: 14664658
[TBL] [Abstract][Full Text] [Related]
10. A Single-Center Experience of the Optimal Initial Immunosuppressive Strategy for Preventing Early Acute Cellular Rejection in Orthotopic Heart Transplantation Associated With Renal Dysfunction.
Mundisugih J; Fernando H; Bergin P; Hare J; Kaye D; Leet A; McGiffin D; Taylor AJ
Prog Transplant; 2019 Dec; 29(4):327-334. PubMed ID: 31476958
[TBL] [Abstract][Full Text] [Related]
11. The Spectrum of Tigecycline-Induced Pancreatitis in Clinical Characteristics, Diagnosis, and Management.
Pan J; Ye C; Zhou LZ; Li ZY; Wang J; He X; Chen SJ; Zhou GQ
Int J Gen Med; 2023; 16():2971-2979. PubMed ID: 37465554
[TBL] [Abstract][Full Text] [Related]
12. Prevention of acute rejection with antithymocyte globulin, avoiding corticosteroids, and delaying cyclosporin after renal transplantation.
Cantarovich D; Giral-Classe M; Hourmant M; Dantal J; Blancho G; Lerat L; Moreau A; Soulillou JP
Nephrol Dial Transplant; 2000 Oct; 15(10):1673-6. PubMed ID: 11007839
[TBL] [Abstract][Full Text] [Related]
13. Intraoperative anti-thymocyte globulin-Fresenius (ATG-F) administration as induction immunosuppressive therapy in kidney transplantation.
Abou-Jaoude MM; Almawi WY
Mol Immunol; 2003 Jul; 39(17-18):1089-94. PubMed ID: 12835082
[TBL] [Abstract][Full Text] [Related]
14. Acute rejection features in dual kidney transplant recipients from elderly donors: comparison of calcineurin inhibitor-based and calcineurin inhibitor-free immunosuppressive protocols.
Aiello FB; Furian L; Marino S; Marchini F; Cardillo M; De Fazio N; Rigotti P; Valente M
Int J Immunopathol Pharmacol; 2009; 22(4):1001-7. PubMed ID: 20074463
[TBL] [Abstract][Full Text] [Related]
15. Administration of Antithymocyte Globulin (Rabbit) to Treat a Severe, Mixed Rejection Episode in a Pregnant Renal Transplant Recipient.
Kutzler HL; Ye X; Rochon C; Martin ST
Pharmacotherapy; 2016 Apr; 36(4):e18-22. PubMed ID: 26892892
[TBL] [Abstract][Full Text] [Related]
16. Belatacept prophylaxis against organ rejection in adult kidney-transplant recipients.
Del Bello A; Marion O; Milongo D; Rostaing L; Kamar N
Expert Rev Clin Pharmacol; 2016; 9(2):215-27. PubMed ID: 26691282
[TBL] [Abstract][Full Text] [Related]
17. Tigecycline-associated acute pancreatitis in a child with pulmonary cystic fibrosis: A case report and literature review.
Chang C; Qiao W; Wang H; Zhang X
Int J Clin Pharmacol Ther; 2022 Jan; 60(1):41-45. PubMed ID: 34605395
[TBL] [Abstract][Full Text] [Related]
18. Basiliximab versus antithymocyte globulin for prevention of acute renal allograft rejection.
Sollinger H; Kaplan B; Pescovitz MD; Philosophe B; Roza A; Brayman K; Somberg K
Transplantation; 2001 Dec; 72(12):1915-9. PubMed ID: 11773888
[TBL] [Abstract][Full Text] [Related]
19. Acute pancreatitis caused by tigecycline and furosemide combination treatment and hypofibrinogenemia caused by tigecycline: A case report.
Li ZK; Zheng P
Int J Clin Pharmacol Ther; 2023 Oct; 61(10):466-470. PubMed ID: 37548456
[TBL] [Abstract][Full Text] [Related]
20. Impact of the addition of maintenance steroids to a rapid steroid discontinuation immunosuppressive protocol following acute renal transplant rejection.
Arora S; Marcus RJ; Dikkala S; Sureshkumar KK
Exp Clin Transplant; 2009 Dec; 7(4):233-6. PubMed ID: 20353373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
